$PRG

The Insiders Fund Not So Daily Podcast | Insider Buy Sell Ratio

Insider Buying Week 05-16-25 The Best Insider Buy/Sell Ratio in a Year

by

  The busiest week we’ve seen in some time.  In fact, it’s so busy that I would venture to say that a short-term bottom is in and there is a more room to the upside.  It’s basically all in now and I don’t often make a call like that. Of course, we won’t know that for months, but this is the most bullish Insider Buy/Sell Ratio in a year.  At least it gives us a lot to ponder. There are a lot of compelling insider buys this week.  As usual insiders are value buyers, preferring to buy their stocks nearer … Read more

Insider Buying 02-28-25 Be Fearful When Others Are Greedy and Greedy When Others Are Fearful

by

CHAOS 2.0 unfolds as expected with a sharp drop in interest rates as market participants pivot from worrying about inflation to crumbling public sentiment and the likelihood of rising unemployment numbers.  The Atlanta Federal Reserve is projecting a contraction of the nation’s gross domestic product (GDP) of 1.5 percent in the first quarter, flashing a warning sign for the U.S. economy. The projection is a significant shift for the Atlanta Fed over the last few weeks that comes a little more than a month after President Trump took office. The Atlanta Fed last week was predicting 2.3 percent positive growth … Read more

Insider Buying Week 8-5-22 CARVANA NIRVANA

by

  Curious how well insiders are doing with their buys? The Insider Report hit the ball out of the park Friday, August 5th. We hope you were in the stands with us to watch Carvana CVNA soar out of the stadium, up 40%. We have blogged about it several times in the Insiders Report. Numerous short sellers were saying that CVNA was going to go bust, and it reportedly had a short ratio of 40%, one of the largest out there. That means 40% of the holders of Carvana were betting it would go down, not up. Today they felt a … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more